Biogen Files New Drug Application for Aducanumab in Japan

NEXT STORY
Oncternal Therapeutics Increases Previously Announced Bought Deal to $75.0 Million
PREV STORY
ALX Oncology Announces Pricing of Upsized Public Offering of Common Stock
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioXcel Therapeutics Announces Appointment of Reina Benabou, M.D., Ph.D., as Chief Development Officer

author_avatar
NASDAQ Market News

FibroGen Receives Fast Track Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy

author_avatar
NASDAQ Market News

Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared

author_avatar
NASDAQ Market News